These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23704364)

  • 21. Estrous cycle and stress: influence of progesterone on the female brain.
    Lovick TA
    Braz J Med Biol Res; 2012 Apr; 45(4):314-20. PubMed ID: 22450372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.
    Marx CE; Shampine LJ; Khisti RT; Trost WT; Bradford DW; Grobin AC; Massing MW; Madison RD; Butterfield MI; Lieberman JA; Morrow AL
    Pharmacol Biochem Behav; 2006 Aug; 84(4):609-17. PubMed ID: 16996120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy.
    Reddy DS; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):337-44. PubMed ID: 11442150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake.
    Pinna G; Costa E; Guidotti A
    Psychopharmacology (Berl); 2006 Jun; 186(3):362-72. PubMed ID: 16432684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
    Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
    Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurosteroid regulation of GABA
    Joshi S; Kapur J
    Brain Res; 2019 Jan; 1703():31-40. PubMed ID: 29481795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
    Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake.
    Pinna G; Costa E; Guidotti A
    Curr Opin Pharmacol; 2009 Feb; 9(1):24-30. PubMed ID: 19157982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy.
    Reddy DS; Kim HY; Rogawski MA
    Epilepsia; 2001 Mar; 42(3):328-36. PubMed ID: 11442149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice.
    Nelson M; Pinna G
    Neuropharmacology; 2011 Jun; 60(7-8):1154-9. PubMed ID: 20971127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?
    Ho HP; Olsson M; Westberg L; Melke J; Eriksson E
    Neuropsychopharmacology; 2001 May; 24(5):502-10. PubMed ID: 11282250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allopregnanolone concentrations and premenstrual syndrome.
    Monteleone P; Luisi S; Tonetti A; Bernardi F; Genazzani AD; Luisi M; Petraglia F; Genazzani AR
    Eur J Endocrinol; 2000 Mar; 142(3):269-73. PubMed ID: 10700721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology of catamenial epilepsy.
    Reddy DS
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):547-61. PubMed ID: 15538544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GABA receptors, progesterone and premenstrual dysphoric disorder.
    Sundström Poromaa I; Smith S; Gulinello M
    Arch Womens Ment Health; 2003 Feb; 6(1):23-41. PubMed ID: 12715262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
    Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
    Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurosteroid replacement therapy for catamenial epilepsy.
    Reddy DS; Rogawski MA
    Neurotherapeutics; 2009 Apr; 6(2):392-401. PubMed ID: 19332335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin AJ; Akopians AL
    Menopause Int; 2012 Jun; 18(2):52-9. PubMed ID: 22611222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma.
    Pineles SL; Nillni YI; Pinna G; Irvine J; Webb A; Arditte Hall KA; Hauger R; Miller MW; Resick PA; Orr SP; Rasmusson AM
    Psychoneuroendocrinology; 2018 Jul; 93():133-141. PubMed ID: 29727810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GABA in the female brain -- oestrous cycle-related changes in GABAergic function in the periaqueductal grey matter.
    Lovick TA
    Pharmacol Biochem Behav; 2008 Jul; 90(1):43-50. PubMed ID: 18261785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural mechanisms underlying changes in stress-sensitivity across the menstrual cycle.
    Ossewaarde L; Hermans EJ; van Wingen GA; Kooijman SC; Johansson IM; Bäckström T; Fernández G
    Psychoneuroendocrinology; 2010 Jan; 35(1):47-55. PubMed ID: 19758762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.